Manteia (Manteia)

Manteia is committed to innovations in adaptive radiotherapy treatment through intensive research in artificial intelligence, data analysis and advanced algorithms. The company's product line includes AccuContour™ (RT Image Processing Solutions), AccuPlan™ (online adaptive TPS based on CBCT/MR) and AccuLearning™ (AI model server), aiming to bring adaptive RT solutions to clinical practice. Manteia works closely with world-leading cancer centers to bring translational research into clinical applications. In the past 2 years, their solutions have supported more than two hundred cancer centers and have provided better care for thousands of cancer patients worldwide by making oncology software faster, safer and more intelligent.

60.9logo
logo
logo
logo
logo
logo
60.9
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logo
Valuation
logo
$
Valuation
Funding
logo
$
$ 15.44 M
$ 32.28 M
Funding
$ 15.44 M
$ 32.28 M
Statistics
logo
NA
Action

Manteia is committed to innovations in adaptive radiotherapy treatment through intensive research in artificial intelligence, data analysis and advanced algorithms. The company's product line includes AccuContour™ (RT Image Processing Solutions), AccuPlan™ (online adaptive TPS based on CBCT/MR) and AccuLearning™ (AI model server), aiming to bring adaptive RT solutions to clinical practice. Manteia works closely with world-leading cancer centers to bring translational research into clinical applications. In the past 2 years, their solutions have supported more than two hundred cancer centers and have provided better care for thousands of cancer patients worldwide by making oncology software faster, safer and more intelligent.

0and0